The researchers, among them Jose Luis Fernandez Moon (Molecular Genetics Unit) and Victor Taboada Mtnez (S. Rheumatology) analyzed in paper ASCC1 (activating signal cointegrator 1 complex subunit 1) a potent inhibitor of NFkB activation and They conclude that an inactive variant ASCC1 contributes to prognosis of patients with rheumatoid arthritis.
The study of the known key implication of NFKB in the phenomena of inflammation that are the central phenomenon of Rheumatoid Arthritis. In the first phase of the study analyzed 158 regulators NFkB pathway in patients with rheumatoid arthritis using techniques Next-generation sequencing in patients with rheumatoid arthritis and healthy controls, and this analysis ASCC1 selected for study.
Having established the role of the inactive variant ASCC1, analysis of more than 400 patients with rheumatoid arthritis for the first time to detect an association between the inactive variant and severity of rheumatoid arthritis. The study is being replicated in a larger cohort.
The article was published in the prestigious Journal of Immunology and cited and summarized in Nature Review Rheumatology.
Un estudio con datos de los últimos 35 años, ind...
Un equipo de investigadores de la Universidad Juli...
A new technique allows the design of solid materia...
En nuestro post hablamos sobre este interesante tipo de célula del...
Han desarrollado un estudio para evaluar la correlación entre el teji...
Biotechnology portal in Spain
Subscribe to our newsletter and stay up to date with the latest news and deals!
2013 © Biotech-Spain.com - Site Developments SL. All Rights Reserved. Terms of Service | Privacy Policy
Articles
Directory